← Back to Search

Cognitive Training for Mild Cognitive Impairment

N/A
Waitlist Available
Led By Karen A Chipman, PhD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical diagnosis of Mild Cognitive Impairment
Must not have
History of neurological conditions known to impair cognition
Clinical diagnosis of dementia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline and months 3, 5, 8
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if a new cognitive training program is helpful for people with Mild Cognitive Impairment. The program will focus on everyday memory issues, use problem-solving techniques, and include a diverse

Who is the study for?
This trial is for seniors with a clinical diagnosis of Mild Cognitive Impairment. It's designed to help those who struggle with everyday memory problems and may also have mild mood-related symptoms.
What is being tested?
The study tests a cognitive training program focused on improving daily memory issues in seniors with Mild Cognitive Impairment. The program includes traditional memory exercises and problem-solving techniques.
What are the potential side effects?
Since the intervention involves cognitive training, there are no direct physical side effects expected. Participants might experience mental fatigue or frustration if they find tasks challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Mild Cognitive Impairment.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a neurological condition that affects my thinking.
Select...
I have been diagnosed with dementia.
Select...
I am experiencing moderate to severe symptoms of depression or anxiety.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline and months 3, 5, 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline and months 3, 5, 8 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in everyday memory functioning
Secondary study objectives
Change in caregiver burden
Change in memory perception
Change in mood (i.e., self-report symptoms of anxiety)
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive trainingExperimental Treatment1 Intervention
Group II: No cognitive trainingActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive training
2019
Completed Phase 3
~1480

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,522 Total Patients Enrolled
Karen ChipmanLead Sponsor
Nova Scotia Health Research FoundationOTHER_GOV
14 Previous Clinical Trials
34,012 Total Patients Enrolled
~3 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top